High-end mass spectroscopy innovation is driven by proteomics, leaving scientists in other fields like drug development, environmental analysis, and metabolomics underserved.
Kelly Moser
Advertisement
Kelly Wormwood Moser is leading Mobilion’s application development, working with industry collaborators to develop methods to demonstrate HRIM separation capabilities with biological samples. Kelly is leveraging her Ph.D. research experience, where, under the direction of Dr. Costel Darie, she used mass spectrometry to identify potential protein biomarker signatures for autism spectrum disorders.
Articles by Kelly Moser
HRIM has emerged as a robust separation strategy for complex chemical analyses due to its ability to improve peak capacity and aid in the separation of isobaric signals.
Advertisement
Latest Updated Articles
The Role of IM-HRMS Outside ProteomicsMay 27th 2026
Advertisement
Advertisement
Trending on LCGC International
1
GC–MS Maps Sugar Compounds in Sweet Corn
2
Advanced Gas Chromatography Methods for Detecting PFAS Contamination in Soil
3
LC–MS/MS Detects MCI/MI in Danish Soaps and Shampoos
4
DDA vs DIA: Weighing Spectral Quality Against Setup Complexity
5